Clinical Trial Update: A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine [Phase 3]

View source ↗

Summary

A Phase III clinical trial comparing entecavir to lamivudine in adults with chronic hepatitis B who had an incomplete response to lamivudine; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• Lamivudine (lamivudine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Hepatitis B | Phase 3 | Status: COMPLETED